A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents and Children With Suspected or Confirmed Bacterial Infection
Phase of Trial: Phase I
Latest Information Update: 11 Jun 2017
At a glance
- Drugs Solithromycin (Primary) ; Solithromycin (Primary) ; Solithromycin (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Sponsors Cempra Pharmaceuticals
- 13 Nov 2016 Status changed from recruiting to completed.
- 12 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Oct 2016.
- 10 May 2016 This trial was discontinued in Bulgaria, according to European Clinical Trials Database record.